Treatment of chronic axial back pain with 60‐day percutaneous medial branch PNS: Primary end point results from a prospective, multicenter study

Abstract

Given the minimally invasive, nondestructive nature of percutaneous PNS and the significant benefits experienced by participants who were recalcitrant to nonsurgical treatments, percutaneous PNS may provide a promising first-line neurostimulation treatment option for patients with chronic axial back pain.